Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+231.1%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+231.1%/yr
vs -79.3%/yr prior
Acceleration
+310.4pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
36.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 779.57% |
| Q2 2025 | 89.95% |
| Q1 2025 | -474.02% |
| Q4 2024 | 108.30% |
| Q3 2024 | -49.34% |
| Q2 2024 | -339.10% |
| Q1 2024 | -121.44% |
| Q4 2023 | 159.26% |
| Q3 2023 | -590.55% |
| Q2 2023 | -72.73% |
| Q1 2023 | -56.01% |
| Q4 2022 | -42.99% |
| Q3 2022 | 21.48% |
| Q2 2022 | -24.82% |
| Q1 2022 | -41.80% |
| Q4 2021 | 13.67% |
| Q3 2021 | -34.79% |
| Q2 2021 | 448.05% |
| Q1 2021 | -39.21% |
| Q4 2020 | -92.58% |
| Q3 2020 | -12.24% |
| Q2 2020 | 1353.88% |
| Q1 2020 | -104.01% |
| Q4 2019 | 0.01% |
| Q3 2019 | -2.58% |
| Q2 2019 | 3595.63% |
| Q1 2019 | -102.89% |
| Q4 2018 | -43.44% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |